Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Orphanet Journal of Rare Diseases|June 23, 2019
Treatment with metformin in twelve patients with Lafora diseaseFrancesca Bisulli, Lorenzo Muccioli, Giuseppe d'Orsi, et al.Journal of Clinical Medicine|July 14, 2023
Personality Traits and Fatigue in Multiple Sclerosis: A Narrative ReviewAlessia Ciancio, Maria Claudia Moretti, Antimo Natale, et al.Seizure|November 5, 2020
The presenting symptoms of Lafora Disease: An electroclinical and genetic study in five Apulian (Southern Italy) familiesGiuseppe d'Orsi, Alessandra Lalla, Orazio Palumbo, et al.Redox Biology|August 16, 2023
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's diseaseMoris Sangineto, Martina Ciarnelli, Tommaso Cassano, et al.Cellular and Molecular Neurobiology|September 17, 2024
Lactobacilli Cell-Free Supernatants Modulate Inflammation and Oxidative Stress in Human Microglia via NRF2-SOD1 SignalingMariagiovanna Di Chiano, Maria Teresa Rocchetti, Giuseppe Spano, et al.Therapeutic Advances in Neurological Disorders|March 5, 2026
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practiceAurora Zanghì, Giovanna Borriello, Matteo Foschi, et al.Plos One|July 7, 2011
T regulatory cells are markers of disease activity in multiple sclerosis patientsDacia Dalla Libera, Diletta Di Mitri, Alessandra Bergami, et al.Journal of Neurology|May 4, 2024
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched studyAurora Zanghì, Giovanna Borriello, Simona Bonavita, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 29, 2022
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 PandemicAurora Zanghì, Carlo Avolio, Elisabetta Signoriello, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2025
Multiple sclerosis from onset to secondary progression: a 30-year Italian register studyAurora Zanghì, Massimiliano Copetti, Carlo Avolio, et al.Pageof 9